GABELLI FUNDS LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$132,000
-35.0%
110,900
-1.8%
0.00%
-50.0%
Q2 2022$203,000
-12.5%
112,900
-1.7%
0.00%0.0%
Q1 2022$232,000
-22.1%
114,900
+4.5%
0.00%0.0%
Q4 2021$298,000
-39.2%
109,9000.0%0.00%
-33.3%
Q3 2021$490,000
-19.4%
109,900
+4.8%
0.00%
-25.0%
Q2 2021$608,000
-13.3%
104,900
+5.0%
0.00%
-20.0%
Q1 2021$701,000
-5.8%
99,900
-35.6%
0.01%0.0%
Q4 2020$744,000
-16.0%
155,100
+2.1%
0.01%
-28.6%
Q3 2020$886,000
-10.3%
151,900
+3.8%
0.01%
-12.5%
Q2 2020$988,000
+4.0%
146,400
-2.0%
0.01%0.0%
Q1 2020$950,000
-38.6%
149,400
+0.7%
0.01%
-20.0%
Q4 2019$1,547,000
+165.4%
148,4000.0%0.01%
+150.0%
Q3 2019$583,000
-64.0%
148,400
+36.3%
0.00%
-60.0%
Q2 2019$1,619,000
+46.0%
108,900
+143.6%
0.01%
+42.9%
Q1 2019$1,109,000
+313.8%
44,700
+200.0%
0.01%
+250.0%
Q4 2018$268,000
+32.0%
14,900
+115.9%
0.00%
+100.0%
Q3 2018$203,000
-17.5%
6,900
+27.8%
0.00%0.0%
Q2 2018$246,000
-81.7%
5,400
-78.7%
0.00%
-87.5%
Q1 2018$1,341,000
+6.6%
25,400
+37.3%
0.01%
+14.3%
Q4 2017$1,258,000
-0.9%
18,500
+20.1%
0.01%0.0%
Q3 2017$1,269,000
+54.0%
15,400
+75.0%
0.01%
+40.0%
Q2 2017$824,0008,8000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders